{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:11:21Z","timestamp":1791803481561,"version":"4.3.4"},"reference-count":110,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Neonatal hypoxic ischemic encephalopathy (HIE) presents a significant clinical burden with its high mortality and morbidity rates globally. Therapeutic hypothermia (TH) is now standard of care for infants with moderate to severe HIE, but has not definitively changed outcomes in severe HIE. In this review, we discuss newer promising markers that may help the clinician identify severity of HIE. Therapies that are beneficial and agents that hold promise for neuroprotection are described, both for use either alone or as adjuncts to TH. These include endogenous pathway modifiers such as erythropoietin and analogues, melatonin, and remote ischemic post conditioning. Stem cells have therapeutic potential in this condition, as in many other neonatal conditions. Of the agents listed, only erythropoietin and analogues are currently being evaluated in large randomized controlled trials (RCTs). Exogenous therapies such as argon and xenon, allopurinol, monosialogangliosides, and magnesium sulfate continue to be investigated. The recognition of tertiary mechanisms of brain damage has opened up new research into therapies not only to attenuate brain damage but also to promote cell repair and regeneration in a developmentally disorganized brain long after the perinatal insult. These alternative modalities may be especially important in mild HIE and in areas of the world where there is limited access to expensive hypothermia equipment and services.<\/jats:p>","DOI":"10.3390\/children5070099","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T02:10:11Z","timestamp":1532052611000},"page":"99","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Current and Emerging Therapies in the Management of Hypoxic Ischemic Encephalopathy in Neonates"],"prefix":"10.3390","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3846-2027","authenticated-orcid":false,"given":"Jayasree","family":"Nair","sequence":"first","affiliation":[{"name":"Division of Neonatology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0950-2608","authenticated-orcid":false,"given":"Vasantha H.S.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,7,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.siny.2015.07.001","article-title":"Millennium development goals 4 and 5: Past and future progress","volume":"20","author":"Gaffey","year":"2015","journal-title":"Semin. Fetal Neonatal. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000320332","article-title":"Reducing global neonatal mortality is possible","volume":"99","author":"Saugstad","year":"2011","journal-title":"Neonatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S543","DOI":"10.1161\/CIR.0000000000000267","article-title":"Part 13: Neonatal resuscitation: 2015 american heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"132","author":"Wyckoff","year":"2015","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMcps050929","article-title":"Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy","volume":"353","author":"Shankaran","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000353948","article-title":"Time is brain: Starting therapeutic hypothermia within three hours after birth improves motor outcome in asphyxiated newborns","volume":"104","author":"Thoresen","year":"2013","journal-title":"Neonatology"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Committee on Fetus and Newborn, Papile, L.A., Baley, J.E., Benitz, W., Cummings, J., Carlo, W.A., Eichenwald, E., Kumar, P., Polin, R.A., and Tan, R.C. (2014). Hypothermia and neonatal encephalopathy. Pediatrics, 133, 1146\u20131150.","DOI":"10.1542\/peds.2014-0899"},{"key":"ref_7","first-page":"278","article-title":"Follow-up of the term infant after hypoxic-ischemic encephalopathy","volume":"11","author":"Robertson","year":"2006","journal-title":"Paediatr. Child Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1474-4422(12)70058-3","article-title":"Tertiary mechanisms of brain damage: A new hope for treatment of cerebral palsy?","volume":"11","author":"Fleiss","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.22489","article-title":"Systemic inflammation disrupts the developmental program of white matter","volume":"70","author":"Favrais","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tins.2007.05.009","article-title":"Neuronal damage accompanies perinatal white-matter damage","volume":"30","author":"Leviton","year":"2007","journal-title":"Trends Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/clinchem\/48.12.2097","article-title":"S100b protein in biological fluids: A tool for perinatal medicine","volume":"48","author":"Michetti","year":"2002","journal-title":"Clin. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.earlhumdev.2017.07.015","article-title":"Protein s100b in umbilical cord blood as a potential biomarker of hypoxic-ischemic encephalopathy in asphyxiated newborns","volume":"112","author":"Zaigham","year":"2017","journal-title":"Early Hum. Dev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/archpedi.157.12.1163","article-title":"Measurement of urinary s100b protein concentrations for the early identification of brain damage in asphyxiated full-term infants","volume":"157","author":"Gazzolo","year":"2003","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpeds.2017.10.060","article-title":"Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy","volume":"194","author":"Massaro","year":"2018","journal-title":"J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.braindev.2003.12.007","article-title":"Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy","volume":"26","author":"Celtik","year":"2004","journal-title":"Brain Dev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kelen, D., Andorka, C., Szabo, M., Alafuzoff, A., Kaila, K., and Summanen, M. (2017). Serum copeptin and neuron specific enolase are markers of neonatal distress and long-term neurodevelopmental outcome. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184593"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1203\/00006450-200104000-00011","article-title":"Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia","volume":"49","author":"Nagdyman","year":"2001","journal-title":"Pediatr. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/187152509787847119","article-title":"Circulating biochemical markers of brain damage in infants complicated by ischemia reperfusion injury","volume":"7","author":"Gazzolo","year":"2009","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1203\/00006450-199503000-00002","article-title":"Glial fibrillary acidic protein in the cerebrospinal fluid: A possible indicator of prognosis in full-term asphyxiated newborn infants?","volume":"37","author":"Blennow","year":"1995","journal-title":"Pediatr. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jpeds.2013.10.067","article-title":"Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy","volume":"164","author":"Chalak","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.braindev.2013.10.007","article-title":"Serum tau protein level serves as a predictive factor for neurological prognosis in neonatal asphyxia","volume":"36","author":"Takahashi","year":"2014","journal-title":"Brain Dev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/PCC.0b013e318291793f","article-title":"Cord blood proteins and multichannel-electroencephalography in hypoxic-ischemic encephalopathy","volume":"14","author":"Walsh","year":"2013","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000370147","article-title":"Serial plasma metabolites following hypoxic-ischemic encephalopathy in a nonhuman primate model","volume":"37","author":"Chun","year":"2015","journal-title":"Dev. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/brain\/awn150","article-title":"Supra- and sub-baseline phosphocreatine recovery in developing brain after transient hypoxia-ischaemia: Relation to baseline energetics, insult severity and outcome","volume":"131","author":"Iwata","year":"2008","journal-title":"Brain"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1471-4159.2008.05662.x","article-title":"Phosphorus magnetic resonance spectroscopy 2 h after perinatal cerebral hypoxia-ischemia prognosticates outcome in the newborn piglet","volume":"107","author":"Cady","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1203\/00006450-199909000-00007","article-title":"Cerebral intracellular lactic alkalosis persisting months after neonatal encephalopathy measured by magnetic resonance spectroscopy","volume":"46","author":"Robertson","year":"1999","journal-title":"Pediatr. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/jp.2016.151","article-title":"Placental transfusion: A review","volume":"37","author":"Katheria","year":"2017","journal-title":"J. Perinatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"d7157","DOI":"10.1136\/bmj.d7157","article-title":"Effect of delayed versus early umbilical cord clamping on neonatal outcomes and iron status at 4 months: A randomised controlled trial","volume":"343","author":"Andersson","year":"2011","journal-title":"BMJ"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"614S","DOI":"10.1093\/ajcn\/85.2.614S","article-title":"Nutrition and the developing brain: Nutrient priorities and measurement","volume":"85","author":"Georgieff","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"E10819","DOI":"10.1073\/pnas.1717337114","article-title":"Vasopressin excites interneurons to suppress hippocampal network activity across a broad span of brain maturity at birth","volume":"114","author":"Spoljaric","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/dmcn.12730","article-title":"Erythropoietin: A novel therapy for hypoxic-ischaemic encephalopathy?","volume":"57","author":"Wu","year":"2015","journal-title":"Dev. Med. Child. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0168-0102(02)00161-X","article-title":"Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation","volume":"44","author":"Sugawa","year":"2002","journal-title":"Neurosci. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnen\/60.4.386","article-title":"Erythropoietin and erythropoietin receptors in human cns neurons, astrocytes, microglia, and oligodendrocytes grown in culture","volume":"60","author":"Nagai","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/156720208784310231","article-title":"Erythropoietin and oxidative stress","volume":"5","author":"Maiese","year":"2008","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1161\/01.STR.0000173406.04891.8c","article-title":"Neonatal hypoxia\/ischemia is associated with decreased inflammatory mediators after erythropoietin administration","volume":"36","author":"Sun","year":"2005","journal-title":"Stroke"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1203\/PDR.0b013e31819d90c8","article-title":"Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus","volume":"65","author":"Juul","year":"2009","journal-title":"Pediatr. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neulet.2008.10.060","article-title":"Effect of erythropoietin on oxygen-induced brain injury in the newborn rat","volume":"448","author":"Yis","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2003.10.006","article-title":"Erythropoietin protects the developing brain against n-methyl-d-aspartate receptor antagonist neurotoxicity","volume":"15","author":"Dzietko","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1542\/peds.2008-3553","article-title":"Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy","volume":"124","author":"Zhu","year":"2009","journal-title":"Pediatrics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e1135","DOI":"10.1542\/peds.2009-2268","article-title":"Human recombinant erythropoietin in asphyxia neonatorum: Pilot trial","volume":"125","author":"Elmahdy","year":"2010","journal-title":"Pediatrics"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1542\/peds.2012-0498","article-title":"Erythropoietin for neuroprotection in neonatal encephalopathy: Safety and pharmacokinetics","volume":"130","author":"Wu","year":"2012","journal-title":"Pediatrics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e20160190","DOI":"10.1542\/peds.2016-0191","article-title":"High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: A phase ii trial","volume":"137","author":"Wu","year":"2016","journal-title":"Pediatrics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000486820","article-title":"High-dose erythropoietin for asphyxia and encephalopathy (heal): A randomized controlled trial\u2014Background, aims, and study protocol","volume":"113","author":"Juul","year":"2018","journal-title":"Neonatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/pr.2015.101","article-title":"Darbepoetin administration to neonates undergoing cooling for encephalopathy: A safety and pharmacokinetic trial","volume":"78","author":"Baserga","year":"2015","journal-title":"Pediatr. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.semperi.2015.12.002","article-title":"Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges","volume":"40","author":"Mitsialis","year":"2016","journal-title":"Semin. Perinatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/pr.2017.260","article-title":"Future perspectives of cell therapy for neonatal hypoxic-ischemic encephalopathy","volume":"83","author":"Nabetani","year":"2018","journal-title":"Pediatr. Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Archambault, J., Moreira, A., McDaniel, D., Winter, L., Sun, L., and Hornsby, P. (2017). Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0189895"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Jellema, R.K., Wolfs, T.G., Lima Passos, V., Zwanenburg, A., Ophelders, D.R., Kuypers, E., Hopman, A.H., Dudink, J., Steinbusch, H.W., and Andriessen, P. (2013). Mesenchymal stem cells induce t-cell tolerance and protect the preterm brain after global hypoxia-ischemia. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073031"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","article-title":"Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy","volume":"164","author":"Cotten","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2014.10.031","article-title":"Remote ischemic conditioning","volume":"65","author":"Heusch","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1177\/1535370217712691","article-title":"Hypoxic conditioning and the central nervous system: A new therapeutic opportunity for brain and spinal cord injuries?","volume":"242","author":"Baillieul","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fphys.2012.00027","article-title":"Remote ischemic conditioning: From bench to bedside","volume":"3","author":"Lim","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Drunalini Perera, P.N., Hu, Q., Tang, J., Li, L., Barnhart, M., Doycheva, D.M., Zhang, J.H., and Tang, J. (2014). Delayed remote ischemic postconditioning improves long term sensory motor deficits in a neonatal hypoxic ischemic rat model. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090258"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5763743","DOI":"10.1155\/2016\/5763743","article-title":"Immediate remote ischemic postconditioning reduces brain nitrotyrosine formation in a piglet asphyxia model","volume":"2016","author":"Rudge","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1203\/01.pdr.0000228839.00122.6c","article-title":"Characterization of the neuroprotective effect of the cannabinoid agonist win-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats","volume":"60","author":"Nunez","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1161\/STROKEAHA.110.599357","article-title":"The cannabinoid win55212-2 promotes neural repair after neonatal hypoxia-ischemia","volume":"41","author":"Pradillo","year":"2010","journal-title":"Stroke"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1203\/PDR.0b013e3181fcb40b","article-title":"Melatonin promotes myelination by decreasing white matter inflammation after neonatal stroke","volume":"69","author":"Villapol","year":"2011","journal-title":"Pediatr. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1600-079X.2007.00490.x","article-title":"Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis","volume":"43","author":"Jou","year":"2007","journal-title":"J. Pineal Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12640-012-9337-4","article-title":"Melatonin antioxidative defense: Therapeutical implications for aging and neurodegenerative processes","volume":"23","author":"BaHammam","year":"2013","journal-title":"Neurotox. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/brain\/aws285","article-title":"Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model","volume":"136","author":"Robertson","year":"2013","journal-title":"Brain"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jp.2014.186","article-title":"Melatonin use for neuroprotection in perinatal asphyxia: A randomized controlled pilot study","volume":"35","author":"Aly","year":"2015","journal-title":"J. Perinatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0633.2002.290401.x","article-title":"Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment","volume":"29","author":"Seabra","year":"2000","journal-title":"J. Pineal Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1034\/j.1600-079X.2001.310409.x","article-title":"Increased levels of malondialdehyde and nitrite\/nitrate in the blood of asphyxiated newborns: Reduction by melatonin","volume":"31","author":"Fulia","year":"2001","journal-title":"J. Pineal Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.2147\/NDT.S115533","article-title":"Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: Light at the end of the tunnel?","volume":"12","author":"Hendaus","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0168-0102(03)00100-7","article-title":"Neonatal hypoxia-ischemia reduces ganglioside, phospholipid and cholesterol contents in the rat hippocampus","volume":"46","author":"Ramirez","year":"2003","journal-title":"Neurosci. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1074\/jbc.270.7.3074","article-title":"Prevention of apoptotic neuronal death by gm1 ganglioside. Involvement of trk neurotrophin receptors","volume":"270","author":"Ferrari","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02815133","article-title":"GM1 monosialoganglioside pretreatment protects against soman-induced seizure-related brain damage","volume":"34","author":"Ballough","year":"1998","journal-title":"Mol. Chem. Neuropathol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Sheng, L., and Li, Z. (2017). Adjuvant treatment with monosialoganglioside may improve neurological outcomes in neonatal hypoxic-ischemic encephalopathy: A meta-analysis of randomized controlled trials. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183490"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.22387","article-title":"Xenon augmented hypothermia reduces early lactate\/N-acetylaspartate and cell death in perinatal asphyxia","volume":"70","author":"Faulkner","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ana.22016","article-title":"Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs","volume":"68","author":"Chakkarapani","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(15)00347-6","article-title":"Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): A proof-of-concept, open-label, randomised controlled trial","volume":"15","author":"Azzopardi","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/EJA.0b013e3283583c4b","article-title":"A xenon recirculating ventilator for the newborn piglet: Developing clinical applications of xenon for neonates","volume":"29","author":"Faulkner","year":"2012","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2015.12.001","article-title":"Inhaled 45\u201350% argon augments hypothermic brain protection in a piglet model of perinatal asphyxia","volume":"87","author":"Broad","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/CCM.0b013e3182452164","article-title":"The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats","volume":"40","author":"Zhuang","year":"2012","journal-title":"Crit. Care Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Yamaguchi, M., Okamoto, K., Kusano, T., Matsuda, Y., Suzuki, G., Fuse, A., and Yokota, H. (2015). The effects of xanthine oxidoreductase inhibitors on oxidative stress markers following global brain ischemia reperfusion injury in C57BL\/6 mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133980"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.brainres.2005.11.061","article-title":"Effect of allopurinol on brain adenosine levels during hypoxia in newborn piglets","volume":"1073\u20131074","author":"Marro","year":"2006","journal-title":"Brain Res."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Rodriguez-Fanjul, J., Duran Fernandez-Feijoo, C., Lopez-Abad, M., Lopez Ramos, M.G., Balada Caballe, R., Alcantara-Horillo, S., and Camprubi Camprubi, M. (2017). Neuroprotection with hypothermia and allopurinol in an animal model of hypoxic-ischemic injury: Is it a gender question?. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184643"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Chaudhari, T., and McGuire, W. (2012). Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy. Cochrane Database Syst. Rev., CD006817.","DOI":"10.1002\/14651858.CD006817.pub3"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"F162","DOI":"10.1136\/archdischild-2011-300356","article-title":"Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: Follow-up of two randomised controlled trials","volume":"97","author":"Kaandorp","year":"2012","journal-title":"Arch. Dis. Child. Fetal Neonatal. Ed."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1542\/peds.2008-2228","article-title":"Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker s-100b","volume":"124","author":"Torrance","year":"2009","journal-title":"Pediatrics"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1651-2227.2000.tb00364.x","article-title":"Serum total magnesium and ionized calcium concentrations in asphyxiated term newborn infants with hypoxic-ischaemic encephalopathy","volume":"89","author":"Ilves","year":"2000","journal-title":"Acta Paediatr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1542\/peds.2007-3642","article-title":"Magnesium sulfate in severe perinatal asphyxia: A randomized, placebo-controlled trial","volume":"123","author":"Bhat","year":"2009","journal-title":"Pediatrics"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000362206","article-title":"Magnesium is not consistently neuroprotective for perinatal hypoxia-ischemia in term-equivalent models in preclinical studies: A systematic review","volume":"36","author":"Galinsky","year":"2014","journal-title":"Dev. Neurosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000484891","article-title":"Magnesium as a neuroprotective agent: A review of its use in the fetus, term infant with neonatal encephalopathy, and the adult stroke patient","volume":"40","author":"Lingam","year":"2018","journal-title":"Dev. Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/jp.2013.65","article-title":"Magnesium for newborns with hypoxic-ischemic encephalopathy: A systematic review and meta-analysis","volume":"33","author":"Tagin","year":"2013","journal-title":"J. Perinatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpeds.2015.02.056","article-title":"Neuroprotection for perinatal hypoxic ischemic encephalopathy in low- and middle-income countries","volume":"167","author":"Tagin","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jpeds.2010.04.019","article-title":"Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: A safety study","volume":"157","author":"Filippi","year":"2010","journal-title":"J. Pediatr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/14767058.2017.1304536","article-title":"Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): A feasibility study","volume":"31","author":"Filippi","year":"2018","journal-title":"J. Matern. Fetal Neonatal. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.expneurol.2015.10.012","article-title":"Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards m2 phenotype","volume":"275","author":"Amantea","year":"2016","journal-title":"Exp. Neurol."},{"key":"ref_91","unstructured":"Barks, J.L.Y., and Silverstein, F. (2018). Repurposing Azithromycin for Neonatal Neuroprotection: Next Steps, PAS."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e20160659","DOI":"10.1542\/peds.2016-0659","article-title":"Early EEG grade and outcome at 5 years after mild neonatal hypoxic ischemic encephalopathy","volume":"138","author":"Murray","year":"2016","journal-title":"Pediatrics"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jpeds.2011.12.052","article-title":"Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?","volume":"160","author":"Robertson","year":"2012","journal-title":"J. Pediatr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ana.22473","article-title":"Opposite effect of inflammation on subventricular zone versus hippocampal precursors in brain injury","volume":"70","author":"Covey","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nn.2855","article-title":"Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination","volume":"14","author":"Fancy","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.22627","article-title":"Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants","volume":"71","author":"Buser","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"11045","DOI":"10.1523\/JNEUROSCI.3652-05.2005","article-title":"Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life","volume":"25","author":"Weaver","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1124\/mol.106.027912","article-title":"Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain","volume":"70","author":"Faraco","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-04-019711","article-title":"Histone deacetylase activities are required for innate immune cell control of th1 but not Th2 effector cell function","volume":"109","author":"Brogdon","year":"2007","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory t cells in an animal model of parkinson\u2019s disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm.2266","article-title":"Microrna-124 promotes microglia quiescence and suppresses eae by deactivating macrophages via the c\/ebp-alpha-pu.1 pathway","volume":"17","author":"Ponomarev","year":"2011","journal-title":"Nat. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1159\/000321607","article-title":"Defining the critical period for neocortical neurogenesis after pediatric brain injury","volume":"32","author":"Covey","year":"2010","journal-title":"Dev. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9603","DOI":"10.1523\/JNEUROSCI.1835-10.2010","article-title":"Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function","volume":"30","author":"Kavelaars","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11481-009-9164-4","article-title":"Heterogeneity of microglial activation in the innate immune response in the brain","volume":"4","author":"Colton","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1172\/JCI119545","article-title":"Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain","volume":"100","author":"Gressens","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuropharm.2009.05.010","article-title":"The ampa receptor positive allosteric modulator, s18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through bdnf synthesis","volume":"57","author":"Liang","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(08)61329-X","article-title":"Therapeutic hypothermia for birth asphyxia in low-resource settings: A pilot randomised controlled trial","volume":"372","author":"Robertson","year":"2008","journal-title":"Lancet"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Pauliah, S.S., Shankaran, S., Wade, A., Cady, E.B., and Thayyil, S. (2013). Therapeutic hypothermia for neonatal encephalopathy in low- and middle-income countries: A systematic review and meta-analysis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058834"},{"key":"ref_109","first-page":"44","article-title":"Maternal nutritional status & practices & perinatal, neonatal mortality in rural andhra pradesh, india","volume":"127","author":"Bamji","year":"2008","journal-title":"Indian J. Med. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.resuscitation.2013.12.006","article-title":"Hypothermia is not neuroprotective after infection-sensitized neonatal hypoxic-ischemic brain injury","volume":"85","author":"Osredkar","year":"2014","journal-title":"Resuscitation"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/5\/7\/99\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:13:07Z","timestamp":1760195587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/5\/7\/99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,19]]},"references-count":110,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7]]}},"alternative-id":["children5070099"],"URL":"https:\/\/doi.org\/10.3390\/children5070099","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,19]]}}}